Welcome to LookChem.com Sign In|Join Free

CAS

  • or
ethyl-3,3-di(benzyl)oxypropanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

134485-30-6

Post Buying Request

134485-30-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

134485-30-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 134485-30-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,4,8 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 134485-30:
(8*1)+(7*3)+(6*4)+(5*4)+(4*8)+(3*5)+(2*3)+(1*0)=126
126 % 10 = 6
So 134485-30-6 is a valid CAS Registry Number.

134485-30-6Relevant articles and documents

Stereocontrolled synthesis of β-2'-deoxypyrimidine nucleosides via intramolecular glycosylations

Xia, Xiaoyang,Wang, Jianying,Hager, Michael W.,Sisti, Nicholas,Liotta, Dennis C.

, p. 1111 - 1114 (1997)

A pyrimidine moiety was tethered at the 3'-β-position of D-threo-furanosides. By carefully controlling the reaction conditions, pyrimidine bases can be delivered to the anomeric center to give of β-pyrimidine nucleosides in good yield and with complete stereocontrol.

Rational hopping of a peptidic scaffold into non-peptidic scaffolds: Structurally novel potent proteasome inhibitors derived from a natural product, belactosin A

Kawamura, Shuhei,Unno, Yuka,Hirokawa, Takatsugu,Asai, Akira,Arisawa, Mitsuhiro,Shuto, Satoshi

supporting information, p. 2445 - 2447 (2014/03/21)

Rational scaffold hopping of a natural product belactosin A derivative was successfully achieved based on the pharmacophore model constructed. The peptidic scaffold was replaced by significantly simplified non-peptidic scaffolds, by which weak belactosin A (IC50 = 1440 nM) was converted into highly potent non-peptidic inhibitors (IC50 = 26-393 nM).

COMPLEXES OF 4-HYDROPEROXY IFOSFAMIDE AS ANTI-TUMOR AGENTS

-

Page/Page column 22-23, (2010/09/17)

The present disclosure concerns complexes of 4-hydroperoxy ifosfamide. In one embodiment the complexes can be represented by the formula (A); wherein A represents an ammonium species selected from the conjugate acid of a basic amino acid, quaternary ammonium, aliphatic ammonium, heterocyclic ammonium, aromatic ammonium, substituted and unsubstituted pyridinium, guanidinium, and amidinium, and wherein X and Y independently represent leaving groups. Also disclosed herein are methods for making such compounds and formulating pharmaceutical compositions thereof. Methods for administering the disclosed compounds to subjects, particularly to treat hyperproliferative disorders, also are disclosed.

Preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides from acyclic, achiral precursors

-

, (2008/06/13)

A process for the preparation of 3'-substituted-2',3'-dideoxynucleosides is provided that utilizes inexpensive, non-carbohydrate, acyclic, achiral starting materials and that proceeds with high enantiomeric and stereochemical control. The method can be used to prepare the pharmaceutically important compounds 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-fluoro-3'-deoxythymidine, and 3'-fluoro-3'-deoxyuridine.

An efficient synthesis of 3′-fluoro-3′-deoxythymidene (FLT)

Hager, Michael W.,Liotta, Dennis C.

, p. 7083 - 7086 (2007/10/02)

A synthetic route which permits the regioselective introduction of fluoride into an FLT precursor under mild conditions and the subsequent conversion of that intermediate into FLT is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 134485-30-6